메뉴 건너뛰기




Volumn 10, Issue 8, 2012, Pages 543-545

Using ligands to target cancer cells

Author keywords

[No Author keywords available]

Indexed keywords

BIND 014; DOCETAXEL; NANOCARRIER; NANOPARTICLE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; UNCLASSIFIED DRUG;

EID: 84868270139     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (12)

References (8)
  • 1
    • 84875252377 scopus 로고    scopus 로고
    • A Phase I, Open Label, Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation Study of BIND-014 Given By IV Infusion to Patients With Advanced Or Metastatic Cancer
    • www.ClinicalTrials.Gov. Identifer: NCT01300533. Accessed July 17
    • www.ClinicalTrials.Gov. A phase I, open label, safety, pharmacokinetic and pharmacodynamic dose escalation study of BIND-014 given by IV infusion to patients with advanced or metastatic cancer. http://clinicaltrials.gov/ct2/show/NCT01300533. Identifer: NCT01300533. Accessed July 17, 2012.
    • (2012)
  • 2
    • 84875233739 scopus 로고    scopus 로고
    • Abstract LB-452: A phase I, open label, safety, pharmacokinetic and pharmacodynamic dose escalation study of BIND-014 given by IV infusion to patients with advanced or metastatic cancer
    • Abstract LB-452
    • Summa J, LoRusso PM, Eisenberg P, et al. Abstract LB-452: a phase I, open label, safety, pharmacokinetic and pharmacodynamic dose escalation study of BIND-014 given by IV infusion to patients with advanced or metastatic cancer. Cancer Res (AACR Annual Meeting Abstracts). 2012;72(8 suppl): Abstract LB-452.
    • (2012) Cancer Res (AACR Annual Meeting Abstracts) , vol.72 , Issue.8 SUPPL.
    • Summa, J.1    Lorusso, P.M.2    Eisenberg, P.3
  • 3
    • 84858652159 scopus 로고    scopus 로고
    • Targeted polymeric therapeutic nanoparticles: Design, development and clinical translation
    • Kamaly N, Xiao Z, Valencia PM, Radovic-Moreno AF, Farokhzad OC. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev. 2012;41:2971-3010.
    • (2012) Chem Soc Rev , vol.41 , pp. 2971-3010
    • Kamaly, N.1    Xiao, Z.2    Valencia, P.M.3    Radovic-Moreno, A.F.4    Farokhzad, O.C.5
  • 4
    • 84856153806 scopus 로고    scopus 로고
    • Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection
    • Xiao Z, Levy-Nissenbaum E, Alexis F, et al. Engineering of targeted nanoparticles for cancer therapy using internalizing aptamers isolated by cell-uptake selection. ACS Nano. 2012;24;6:696-704.
    • (2012) ACS Nano , vol.24 , Issue.6 , pp. 696-704
    • Xiao, Z.1    Levy-Nissenbaum, E.2    Alexis, F.3
  • 5
    • 84861442552 scopus 로고    scopus 로고
    • Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery
    • Karve S, Werner ME, Sukumar R, et al. Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery. Proc Natl Acad Sci U S A. 2012;109:8230-8235.
    • (2012) Proc Natl Acad Sci U S A , vol.109 , pp. 8230-8235
    • Karve, S.1    Werner, M.E.2    Sukumar, R.3
  • 6
    • 77956434412 scopus 로고    scopus 로고
    • Nanotechnology in drug delivery and tissue engineering: From discovery to applications
    • Shi J, Votruba AR, Farokhzad OC, Langer R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett. 2010;10:3223-3230.
    • (2010) Nano Lett , vol.10 , pp. 3223-3230
    • Shi, J.1    Votruba, A.R.2    Farokhzad, O.C.3    Langer, R.4
  • 7
    • 84858665432 scopus 로고    scopus 로고
    • Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a diferentiated pharmacological profle
    • Hrkach J, Von Hof D, Mukkaram Ali M, et al. Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a diferentiated pharmacological profle. Sci Transl Med. 2012;4:128ra39.
    • (2012) Sci Transl Med , vol.4
    • Hrkach, J.1    von Hof, D.2    Mukkaram Ali, M.3
  • 8
    • 0019336776 scopus 로고
    • Antibody targeting of liposomes: Cell specifcity obtained by conjugation of F(ab')2 to vesicle surface
    • Heath TD, Fraley RT, Papahdjopoulos D. Antibody targeting of liposomes: cell specifcity obtained by conjugation of F(ab')2 to vesicle surface. Science. 1980;210:539-541.
    • (1980) Science , vol.210 , pp. 539-541
    • Heath, T.D.1    Fraley, R.T.2    Papahdjopoulos, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.